Skip to content
Review Open access

Abstract 1308: Enhanced Recovery After Surgery (ERAS) in Elective Craniotomy: An Updated Systematic Review and Meta-Analysis with Pathology-Stratified Subgroup Analysis

Oct 2026 · Stroke: Vascular and Interventional Neurology · 0 citations

Abstract

Background: Elective craniotomy is associated with a significant surgical stress response that may contribute to post-craniotomy morbidity including delayed recovery, poor functional outcomes, and mortality. Enhanced Recovery After Surgery (ERAS) pathways can diminish this response by implementing evidence-based perioperative interventions. The purpose of this updated systematic review and meta-analysis was to assess the safety and efficacy of ERAS protocols for patients undergoing elective craniotomy for different intracranial pathologies. Methods: This systematic review and meta-analysis was performed according to the PRISMA guidelines. A comprehensive literature search was conducted across PubMed, Embase, Cochrane, and ClinicalTrials.gov from inception up to July 25, 2026. Randomized Controlled Trials (RCTs) evaluating ERAS protocols versus conventional perioperative care in adult patients (≥18 years) undergoing elective craniotomy were included. The primary outcome was total hospital length of stay (LOS). Secondary outcomes included hospitalization costs, pain scores, functional recovery, and surgical and non-surgical complications. Data were synthesized using random-effects meta-analysis models. Heterogeneity was quantified using the I² statistic. Furthermore, pathology-based subgroup analysis and leave-one-out sensitivity analyses were performed to identify potential source of heterogeneity. Risk of bias was analyzed using the Cochrane RoB 2 tool, and evidence certainty was evaluated via the GRADE framework. Results: A total of 10 randomized controlled trials comprising 1500 patients were included in the systematic review. Random-effects meta-analysis revealed that Enhanced Recovery After Surgery (ERAS) protocols were associated with a significant reduction in the total hospital Length Of Stay (LOS) (MD = -2.36 days; 95% CI: -3.37 to -1.36; p < 0.0001; I² = 87.9%) and reduced hospitalization costs (MD = -13.75; 95% CI: -18.37 to -9.12). The pathology-based analysis demonstrated that surgical indication was the major source of heterogeneity for LOS (p=0.0110), with neuro-vascular populations exhibiting the most homogenous response (I² = 0), while neuro-oncology patients displayed the largest variance in LOS (I² = 91.7) without reaching statistical significance. ERAS was related to a reduction in postoperative pain scores on Postoperative Day 1 (MD = -1.29) and Postoperative Day 3 (MD = -1.60), a higher probability of achieving favorable pain endpoints (RR = 2.81), and reduced analgesic requirements (RR = 0.68). Furthermore, ERAS showed short-term improvement in functional recovery at discharge (MD = 6.75; though noted as methodologically sensitive) and increased early oral intake (RR = 1.97), alongside a significantly reduced risk of postoperative nausea and vomiting (RR = 0.60) and respiratory complications (RR = 0.38). Safety profiles were comparable, with no significant differences between groups regarding surgical site infections, intracranial infections, postoperative hemorrhage, or seizures. The readmission and reoperation rates were not reached due to low event counts. Conclusion: Multidisciplinary ERAS protocols for elective craniotomy are associated with reduced length of hospital stay, costs, postoperative pain, pulmonary complications while improving early oral intake and functional recovery after discharge without an increase in overall postoperative morbidity and readmission rates. However, because the treatment effects and heterogeneity vary significantly across distinct intracranial pathologies, future research must prioritize pathology-specific protocols to optimize recovery process.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.